Name: Net Profit Margin

Definition: Net profit margin shows how much profit remains after paying all costs — including operating expenses, interest, and taxes — for every dollar of sales. A higher margin means the business is efficient and keeps more of its sales as bottom-line profit. Falling margins may signal rising costs or pricing pressure.

Interpretation:
• In '2022', NAMS's net profit margin was -22.0%, measuring the overall profitability of the company. Industry average for Biotechnology: Pharmaceutical Preparations in '2022' stood at -162.3%.
• In '2023', NAMS's net profit margin was -1255.8%, measuring the overall profitability of the company. The decline from '2022' may indicate some operational or financial challenges. Industry average for Biotechnology: Pharmaceutical Preparations in '2023' stood at -155.0%. Industry average increased by 7.3% compared to previous year.
• In '2024', NAMS's net profit margin was -530.2%, measuring the overall profitability of the company. The increase since '2023' reflects strengthening financial performance. Industry average for Biotechnology: Pharmaceutical Preparations in '2024' stood at -143.4%. Industry average increased by 11.5% compared to previous year.
Overall, NAMS's net profit margin has been volatile but showed a downward trend over the past 3 years.

Formula: Net Profit Margin = Net Income / Revenue

Good Range: Ranges 5%-20% for many industries.